Table 2.
Rome IV criteria |
Criteria used in studies of pharmacologic agents |
||
---|---|---|---|
FC | IBS-C | FC169 | IBS-C170 |
Symptoms for ≥6 mo and 2 or more of the following symptoms for >25% of defecations during past 3 mo: ∘ Straining ∘ Lumpy or hard stools ∘ Sensation of incomplete evacuation ∘ Sensation of anorectal obstruction/blockade ∘ Manual maneuvers to facilitate defecations; ∘ <3 defecations/wk ∘ Loose stools are not present, and there are insufficient criteria for IBS |
Recurrent abdominal pain at least 1 d/wk in the past 3 mo associated with 2 or more of the following: ∘ Related to defecation ∘ Onset associated with change in frequency of stool ∘ Onset associated with change in form (appearance) of stool ∘ >25% of bowel movements were hard and <25% were loose stools |
<3 SBMs/wk and 1 or more of the following symptoms for at least 12 wk during the preceding 12 mo ∘ Straining in >25% of defecations ∘ Lumpy or hard stools in >25% of defecations ∘ Sensation of incomplete evacuation in >25% of defecations ∘ No loose or watery SBMs (Bristol Stool Form Scale scores of 6 or 7) |
Abdominal pain associated with 2 or more of the following: ∘ Related to defecation ∘ Onset associated with change in frequency of stool ∘ Onset associated with change in form and (appearance) of stool ∘ <3 SBMs and <3 CSBMs/wk; and at least 1 additional symptom ∘ Straining in ≥25% of defecations ∘ Lumpy or hard stools in ≥25% of defecations ∘ Sensation of incomplete evacuation in ≥25% of defecations |
CSBM, complete spontaneous bowel movements; SBM, spontaneous bowel movement.